| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/12/2002 | US6346416 Antisense inhibition of HPK/GCK-like kinase expression |
| 02/12/2002 | US6346411 DNA encoding—candida albicans integrin-like protein |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346406 Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor |
| 02/12/2002 | US6346398 Ribozyme or antisense nucleic acid which inhibits synthesis, gene expression and/or stability of messenger rna encoding the flt-1 receptor of human or mouse receptor; treatment of diabetic retinopathy; angiogenesis inhibitors |
| 02/12/2002 | US6346396 MurA |
| 02/12/2002 | US6346395 Nucleic acids encoding Streptococcus pneumoniae FabG |
| 02/12/2002 | US6346393 Polynucleotides encoding a ribonuclease s |
| 02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
| 02/12/2002 | US6346382 Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto |
| 02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |
| 02/12/2002 | US6346274 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
| 02/12/2002 | US6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | US6346244 Fungal protein disulfide isomerase |
| 02/12/2002 | US6346243 Administering interferon to animals to inhibit rejection of transplanted organs |
| 02/12/2002 | US6346242 Compounds and compositions for delivering active agents |
| 02/12/2002 | US6346233 Composition for treating cancer via liposomal aerosol formulation containing taxol |
| 02/12/2002 | US6346098 Methods and kits for locally administering an active agent to an interstitial space of a host |
| 02/12/2002 | CA2259152C Adenovirus e4 proteins for inducing cell death |
| 02/12/2002 | CA2223776C Method of treatment for lung diseases using antisense oligonucleotides |
| 02/12/2002 | CA2176771C Pharmaceutical preparation with modulatory effect on malign tumours and its usage |
| 02/12/2002 | CA2079780C Methods and formulations for stabilizing fibroblast growth factor |
| 02/12/2002 | CA2073453C Methods of enhancing wound healing and tissue repair |
| 02/12/2002 | CA2068204C Latency associated peptides and uses therefor |
| 02/12/2002 | CA2066491C Human neurokinin-1 receptor |
| 02/12/2002 | CA2031817C Use of thrombospondin to promote wound healing |
| 02/12/2002 | CA1341339C Arg-serpin human plasminogen activator inhibitor designated pai-2 |
| 02/11/2002 | CA2740282A1 Purification of hbv antigens for use in vaccines |
| 02/07/2002 | WO2002010743A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 02/07/2002 | WO2002010410A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
| 02/07/2002 | WO2002010409A1 Antisense inhibition of her-3 expression |
| 02/07/2002 | WO2002010408A1 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same |
| 02/07/2002 | WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | WO2002010405A2 A human disintegrin protein |
| 02/07/2002 | WO2002010404A2 Regulation of human masp-like serine protease |
| 02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 02/07/2002 | WO2002010402A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | WO2002010401A2 18431 and 32374, human protein kinase family members and uses therefor |
| 02/07/2002 | WO2002010393A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | WO2002010392A2 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | WO2002010389A2 Human ion channel proteins and polynucleotides encoding the same |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010380A1 A novel polypeptide, a kruppel-like zinc finger protein zk110.12 and the polynucleotide encoding the polypeptide |
| 02/07/2002 | WO2002010379A2 Modified cea and uses thereof |
| 02/07/2002 | WO2002010378A2 Antisense modulation of ptp1b expression |
| 02/07/2002 | WO2002010371A1 Novel physiologically active peptide and use thereof |
| 02/07/2002 | WO2002010366A2 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 02/07/2002 | WO2002010364A2 Methods for enhancing targeted gene alteration using oligonucleotides |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010357A2 Gsk3 polypeptides |
| 02/07/2002 | WO2002010354A2 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin 2) |
| 02/07/2002 | WO2002010339A2 Gene expression profile for kshv infection and methods for treating same |
| 02/07/2002 | WO2002010336A2 Mutacin i biosynthesis genes and proteins |
| 02/07/2002 | WO2002010219A1 Oligolysine transducing domain, oligolysine-cargo molecule complex and uses thereof |
| 02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010215A1 Somatostatin analogs for the treatment of cancer |
| 02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | WO2002010213A1 A novel polypeptide human mitochondrial translational initiation factor 15.4 and a polynucleotide encoding the same |
| 02/07/2002 | WO2002010211A1 A new polypeptide- human zinc finger protein 12.98 and the polynucloetide encoding it |
| 02/07/2002 | WO2002010205A2 Mutations of the mdr1 p-glycoprotein that improve its ability to confer resistance to chemotherapeutic drugs |
| 02/07/2002 | WO2002010202A2 G-protein coupled receptors and nucleic acids encoding same |
| 02/07/2002 | WO2002010201A2 Peptide-mediated delivery of molecules into cells |
| 02/07/2002 | WO2002010200A2 Pas domain proteins |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010198A2 Polynucleotides and polypeptides |
| 02/07/2002 | WO2002010195A2 Modified peptides with increased potency |
| 02/07/2002 | WO2002010194A1 Substance p analogs for the treatment of cancer |
| 02/07/2002 | WO2002010193A1 Lipid-peptide conjugates for treatment of cancer |
| 02/07/2002 | WO2002010192A2 Somatostatin analogues |
| 02/07/2002 | WO2002010185A1 Antisense modulation of lysophospholipase i expression |
| 02/07/2002 | WO2002010184A1 Antisense modulation of her-4 expression |
| 02/07/2002 | WO2002010124A2 Salt forms of an hiv protease inhibitor |
| 02/07/2002 | WO2002009762A2 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 02/07/2002 | WO2002009755A2 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | WO2002009743A1 Method for treating a neoplasm |
| 02/07/2002 | WO2002009742A1 Method for treating a pancreatic disorder with a neurotoxin |
| 02/07/2002 | WO2002009741A1 The pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis |
| 02/07/2002 | WO2002009740A1 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof |
| 02/07/2002 | WO2002009739A1 Treatment of ocular disorders with somatostatin analogues |
| 02/07/2002 | WO2002009737A1 High affinity integrin polypeptides and uses thereof |
| 02/07/2002 | WO2002009736A1 Methods and agents for treating persistent pain |
| 02/07/2002 | WO2002009735A2 Methods and devices to modulate the wound response |
| 02/07/2002 | WO2002009732A2 Method and device for concentrating and stabilising conjugated oestrogens from the urine of mares |
| 02/07/2002 | WO2002009727A1 Compositions and methods for improving cardiovascular function |
| 02/07/2002 | WO2002009718A2 Agents containing corticosteroids for reducing graft rejection reactions |
| 02/07/2002 | WO2002009711A1 Thrombin inhibitors |
| 02/07/2002 | WO2002009700A1 Cancer treatment by combination therapy |
| 02/07/2002 | WO2002009699A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 02/07/2002 | WO2002009668A2 Pulmonary administration of flint |
| 02/07/2002 | WO2002009667A2 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/07/2002 | WO2002009650A2 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 02/07/2002 | WO2002009644A2 Angiogenic and osteogenic proteins for use in enhancing bone density and formation |
| 02/07/2002 | WO2002009642A2 Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel |
| 02/07/2002 | WO2002009641A2 Promyostatin peptides and methods of using same |
| 02/07/2002 | WO2002009639A2 Methods and pharmaceutical compositions for healing wounds |
| 02/07/2002 | WO2002009507A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs |
| 02/07/2002 | WO2001083439A3 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |